Table 6.
Patient groups | Cavernous artery diameter (mm)
|
|||||||
---|---|---|---|---|---|---|---|---|
TPH gel
|
FPH gel
|
|||||||
Before application | After application | Percent increase (%) | P-value | Before application | After application | Percent increase (%) | P-value | |
Normal patient | 0.53±0.076 | 0.78±0.23 | 47 | Significant | 0.65±0.1 | 0.95±0.1 | 46 | Not significant |
Hypertensive patient | 0.62±0.058 | 0.75±0.1 | 22 | Not significant | 0.75±0.15 | 0.95±0.25 | 27 | Not significant |
Diabetic patient | 0.7±0.14 | 1.025±0.035 | 46 | Not significant | 0.7±0.05 | 0.8±0.1 | 14.5 | Not significant |
Note: The values were the means ± standard deviation from three parallel measurements.
Abbreviations: TPH, transferosomal papaverine hydrochloride; FPH, free papaverine hydrochloride.